Biohaven (BHVN) Competitors $15.62 +0.94 (+6.38%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$15.68 +0.06 (+0.40%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHVN vs. RYTM, RNA, AXSM, NUVL, ABVX, CRSP, MRUS, VKTX, CYTK, and AAPGShould you be buying Biohaven stock or one of its competitors? The main competitors of Biohaven include Rhythm Pharmaceuticals (RYTM), Avidity Biosciences (RNA), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Abivax (ABVX), CRISPR Therapeutics (CRSP), Merus (MRUS), Viking Therapeutics (VKTX), Cytokinetics (CYTK), and Ascentage Pharma Group International (AAPG). These companies are all part of the "pharmaceutical products" industry. Biohaven vs. Its Competitors Rhythm Pharmaceuticals Avidity Biosciences Axsome Therapeutics Nuvalent Abivax CRISPR Therapeutics Merus Viking Therapeutics Cytokinetics Ascentage Pharma Group International Biohaven (NYSE:BHVN) and Rhythm Pharmaceuticals (NASDAQ:RYTM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Do institutionals & insiders have more ownership in BHVN or RYTM? 88.8% of Biohaven shares are owned by institutional investors. 16.0% of Biohaven shares are owned by company insiders. Comparatively, 6.1% of Rhythm Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is BHVN or RYTM more profitable? Biohaven has a net margin of 0.00% compared to Rhythm Pharmaceuticals' net margin of -117.13%. Biohaven's return on equity of -270.65% beat Rhythm Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets BiohavenN/A -270.65% -143.70% Rhythm Pharmaceuticals -117.13%-1,831.43%-48.33% Do analysts prefer BHVN or RYTM? Biohaven presently has a consensus target price of $54.23, indicating a potential upside of 247.28%. Rhythm Pharmaceuticals has a consensus target price of $101.57, indicating a potential downside of 1.64%. Given Biohaven's higher possible upside, equities analysts plainly believe Biohaven is more favorable than Rhythm Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biohaven 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 3.07Rhythm Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 3.07 Which has more risk and volatility, BHVN or RYTM? Biohaven has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, Rhythm Pharmaceuticals has a beta of 2.38, indicating that its stock price is 138% more volatile than the S&P 500. Which has higher valuation & earnings, BHVN or RYTM? Rhythm Pharmaceuticals has higher revenue and earnings than Biohaven. Rhythm Pharmaceuticals is trading at a lower price-to-earnings ratio than Biohaven, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiohavenN/AN/A-$846.42M-$7.66-2.04Rhythm Pharmaceuticals$130.13M52.71-$260.60M-$3.01-34.31 Does the media prefer BHVN or RYTM? In the previous week, Biohaven had 34 more articles in the media than Rhythm Pharmaceuticals. MarketBeat recorded 48 mentions for Biohaven and 14 mentions for Rhythm Pharmaceuticals. Rhythm Pharmaceuticals' average media sentiment score of 1.38 beat Biohaven's score of 0.19 indicating that Rhythm Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biohaven 5 Very Positive mention(s) 8 Positive mention(s) 25 Neutral mention(s) 7 Negative mention(s) 0 Very Negative mention(s) Neutral Rhythm Pharmaceuticals 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryBiohaven beats Rhythm Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHVN vs. The Competition Export to ExcelMetricBiohavenMED IndustryMedical SectorNYSE ExchangeMarket Cap$1.65B$3.12B$5.83B$21.32BDividend YieldN/A2.23%4.40%3.51%P/E Ratio-2.0421.0031.3029.14Price / SalesN/A355.64454.6055.18Price / CashN/A44.5038.0224.09Price / Book12.308.129.535.47Net Income-$846.42M-$54.72M$3.26B$992.74M7 Day Performance-0.54%2.62%2.14%2.68%1 Month Performance13.92%2.68%2.81%1.53%1 Year Performance-62.58%10.93%30.70%10.77% Biohaven Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHVNBiohaven3.8219 of 5 stars$15.62+6.4%$54.23+247.3%-60.9%$1.65BN/A-2.04239Trending NewsAnalyst ForecastOptions VolumeGap UpHigh Trading VolumeRYTMRhythm Pharmaceuticals3.8209 of 5 stars$98.09+0.5%$101.57+3.5%+133.7%$6.52B$130.13M-32.59140News CoveragePositive NewsRNAAvidity Biosciences3.1767 of 5 stars$44.48-4.3%$67.00+50.6%+8.2%$5.72B$10.73M-12.49190Positive NewsInsider TradeOptions VolumeAXSMAxsome Therapeutics4.7994 of 5 stars$111.13+1.8%$178.00+60.2%+36.0%$5.55B$385.69M-21.92380News CoveragePositive NewsNUVLNuvalent3.3897 of 5 stars$75.01-1.4%$119.60+59.4%-8.3%$5.41BN/A-15.3140News CoverageAnalyst ForecastInsider TradeABVXAbivax2.9061 of 5 stars$70.01-0.6%$92.33+31.9%+562.8%$5.29BN/A0.0061Positive NewsShort Interest ↑CRSPCRISPR Therapeutics3.7823 of 5 stars$57.59-3.6%$71.60+24.3%+14.4%$5.24B$37.31M-10.61460Positive NewsMRUSMerus2.3111 of 5 stars$66.00-1.9%$88.50+34.1%+26.5%$4.99B$36.13M-12.0037News CoveragePositive NewsVKTXViking Therapeutics3.9956 of 5 stars$42.09+5.1%$86.92+106.5%-59.6%$4.73BN/A-27.5120Trending NewsAnalyst ForecastOptions VolumeCYTKCytokinetics3.7202 of 5 stars$38.95+0.7%$71.58+83.8%-31.8%$4.66B$18.47M-7.64250News CoverageAAPGAscentage Pharma Group InternationalN/A$47.49+5.6%N/AN/A$4.41B$134.35M0.00600News Coverage Related Companies and Tools Related Companies Rhythm Pharmaceuticals Alternatives Avidity Biosciences Alternatives Axsome Therapeutics Alternatives Nuvalent Alternatives Abivax Alternatives CRISPR Therapeutics Alternatives Merus Alternatives Viking Therapeutics Alternatives Cytokinetics Alternatives Ascentage Pharma Group International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHVN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access